151 related articles for article (PubMed ID: 1972009)
1. Deletion mapping on the distal third region of chromosome 1p in multiple endocrine neoplasia type IIA.
Yang KP; Nguyen CV; Castillo SG; Samaan NA
Anticancer Res; 1990; 10(2B):527-33. PubMed ID: 1972009
[TBL] [Abstract][Full Text] [Related]
2. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
Moley JF; Brother MB; Fong CT; White PS; Baylin SB; Nelkin B; Wells SA; Brodeur GM
Cancer Res; 1992 Feb; 52(4):770-4. PubMed ID: 1346584
[TBL] [Abstract][Full Text] [Related]
3. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.
Khosla S; Patel VM; Hay ID; Schaid DJ; Grant CS; van Heerden JA; Thibodeau SN
J Clin Invest; 1991 May; 87(5):1691-9. PubMed ID: 2022740
[TBL] [Abstract][Full Text] [Related]
5. Allele loss on chromosome 10 and point mutation of ras oncogenes are infrequent in tumors of MEN 2A.
Okazaki M; Miya A; Tanaka N; Miki T; Yamamoto M; Motomura K; Miyauchi A; Mori T; Takai S
Henry Ford Hosp Med J; 1989; 37(3-4):112-5. PubMed ID: 2576939
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, management, and pathogenetic studies in medullary thyroid carcinoma syndrome.
Samaan NA; Yang KP; Schultz P; Hickey RC
Henry Ford Hosp Med J; 1989; 37(3-4):132-7. PubMed ID: 2576946
[TBL] [Abstract][Full Text] [Related]
7. Microarray-based CGH of sporadic and syndrome-related pheochromocytomas using a 0.1-0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p.
Aarts M; Dannenberg H; deLeeuw RJ; van Nederveen FH; Verhofstad AA; Lenders JW; Dinjens WN; Speel EJ; Lam WL; de Krijger RR
Genes Chromosomes Cancer; 2006 Jan; 45(1):83-93. PubMed ID: 16215979
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1.
Radford DM; Ashley SW; Wells SA; Gerhard DS
Cancer Res; 1990 Oct; 50(20):6529-33. PubMed ID: 1976436
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
10. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2.
Mulligan LM; Gardner E; Smith BA; Mathew CG; Ponder BA
Genes Chromosomes Cancer; 1993 Mar; 6(3):166-77. PubMed ID: 7682102
[TBL] [Abstract][Full Text] [Related]
11. Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
Sobol H; Narod SA; Schuffenecker I; Amos C; Ezekowitz RA; Lenoir GM
Henry Ford Hosp Med J; 1989; 37(3-4):109-11. PubMed ID: 2576938
[TBL] [Abstract][Full Text] [Related]
12. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
Thakker RV; Bouloux P; Wooding C; Chotai K; Broad PM; Spurr NK; Besser GM; O'Riordan JL
N Engl J Med; 1989 Jul; 321(4):218-24. PubMed ID: 2568587
[TBL] [Abstract][Full Text] [Related]
13. Loss of genes on chromosome 22 in medullary thyroid carcinoma and pheochromocytoma.
Takai S; Tateishi H; Nishisho I; Miki T; Motomura K; Miyauchi A; Kato M; Ikeuchi T; Yamamoto K; Okazaki M
Jpn J Cancer Res; 1987 Sep; 78(9):894-8. PubMed ID: 2889715
[TBL] [Abstract][Full Text] [Related]
14. Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Benn DE; Dwight T; Richardson AL; Delbridge L; Bambach CP; Stowasser M; Gordon RD; Marsh DJ; Robinson BG
Cancer Res; 2000 Dec; 60(24):7048-51. PubMed ID: 11156410
[TBL] [Abstract][Full Text] [Related]
15. Distinct target regions for chromosome 1p deletions in parathyroid adenomas and carcinomas.
Välimäki S; Forsberg L; Farnebo LO; Larsson C
Int J Oncol; 2002 Oct; 21(4):727-35. PubMed ID: 12239610
[TBL] [Abstract][Full Text] [Related]
16. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
[TBL] [Abstract][Full Text] [Related]
17. Familial risk for neuroendocrine tumors.
Anderson RJ; Lynch HT
Curr Opin Oncol; 1993 Jan; 5(1):75-84. PubMed ID: 8094015
[TBL] [Abstract][Full Text] [Related]
18. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
19. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss from chromosome 11 in parathyroid tumors.
Friedman E; De Marco L; Gejman PV; Norton JA; Bale AE; Aurbach GD; Spiegel AM; Marx SJ
Cancer Res; 1992 Dec; 52(24):6804-9. PubMed ID: 1360870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
